Compare · head to head
Mistras vs Quest Diagnostics
Quest Diagnostics ranks higher overall — 360 rank 35 vs 33.
Quest Diagnostics leads on Value (42 vs 35), Quality (62 vs 41) and Safety (54 vs 30). Mistras leads on Growth (72 vs 46) and Sentiment (54 vs 31).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Business Services | Health Care |
| Industry | Professional Services | Health Care Providers & Services |
| Size | Medium | X-Large |
| ISIN | US60649T1079 | US74834L1008 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 33 | 35 |
| Value | 35 | 42 |
| Quality | 41 | 62 |
| Growth | 72 | 46 |
| Safety | 30 | 54 |
| Sentiment | 54 | 31 |
| Quality details | ||
| Profitability | 50 | 68 |
| Cash Truth | 33 | 56 |
Mistras vs LabcorpMistras vs Sotera HealthMistras vs MedpacesMistras vs Charles River LaboratoriesAdd a third stock →
Full analyses: Mistras · Quest Diagnostics
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100